In conclusion, we show that a high breast cancer PRS comes with a comparable risk profile to frameshift mutations in breast cancer susceptibility genes PALB2 and CHEK2, and that the PRS strongly modifies breast cancer risk in the mutation carriers. This evidence concerns the gene CHEK2 and breast cancer.